T Brue
Overview
Explore the profile of T Brue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
1046
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amodru V, Sahakian N, Piazzola C, Appay R, Graillon T, Cuny T, et al.
Pituitary
. 2024 Mar;
27(3):294-302.
PMID: 38521837
Purpose: Acromegaly is a rare disease associated with chronic multisystem complications. New therapeutic strategies have emerged in the last decades, combining pituitary transsphenoidal surgery (TSS), radiotherapy or radiosurgery (RXT) and...
2.
Castets S, Villanueva C, Vergier J, Brue T, Saveanu A, Reynaud R
Arch Pediatr
. 2023 Oct;
28(8S1):8S33-8S38.
PMID: 37870532
Short stature in children can be caused by congenital pituitary disorders involving at least one form of growth hormone deficiency. Clinical and radiological evaluations of the index case and family...
3.
Graillon T, Boissonneau S, Appay R, Boucekine M, Peyriere H, Meyer M, et al.
Neurochirurgie
. 2021 May;
67(6):556-563.
PMID: 33989642
Objective: The aim of this study was to describe progestin-associated meningiomas' characteristics, outcome and management. Material And Methods: We included 53 patients operated on and/or followed in the department for...
4.
Albarel F, Pellegrini I, Rahabi H, Baccou C, Gonin L, Rochette C, et al.
Eur J Endocrinol
. 2020 Oct;
183(6):551-559.
PMID: 33055299
Introduction: The low prevalence of pituitary diseases makes patient autonomy crucial, and self-management programs should be more common. Objectives: To assess the efficacy of an education program for patients with...
5.
Amodru V, Petrossians P, Colao A, Delemer B, Maione L, Neggers S, et al.
Endocrine
. 2020 Jun;
70(1):134-142.
PMID: 32562181
Purpose: Acromegaly is a rare disease due to growth hormone (GH)-secreting pituitary adenoma. GH and IGF-1 levels are usually congruent, indicating either remission or active disease; however, a discrepancy between...
6.
Cuny T, Mac T, Romanet P, Dufour H, Morange I, Albarel F, et al.
Pituitary
. 2019 Jul;
22(5):456-466.
PMID: 31264077
Purpose: Carney complex (CNC) is a rare autosomal dominant syndrome, characterized by mucocutaneous pigmentation, cardiac, cutaneous myxomas and endocrine overactivity. It is generally caused by inactivating mutations in the PRKAR1A...
7.
Albarel F, Castinetti F, Morange I, Guibert N, Graillon T, Dufour H, et al.
Pituitary
. 2018 Oct;
21(6):615-623.
PMID: 30367444
Purpose: To determine whether pre-surgical medical treatment (PSMT) using long-acting Somatostatin analogues in acromegaly may improve long-term surgical outcome and to determine decision making criteria. Methods: This retrospective study included...
8.
Maurice F, Dutour A, Vincentelli C, Abdesselam I, Bernard M, Dufour H, et al.
Eur J Endocrinol
. 2018 Aug;
179(5):307-317.
PMID: 30108093
Objective: Glucocorticoid excess is one of the most important causes of bone disorders. Bone marrow fat (BMF) has been identified as a l new mediator of bone metabolism. Cushing syndrome...
9.
Vermalle M, Alessandrini M, Graillon T, Paladino N, Baumstarck K, Sebag F, et al.
Endocrine
. 2018 Jul;
61(3):518-525.
PMID: 30019306
Introduction: Hypercortisolism leads to severe clinical consequences persisting after the onset of remission. These physical sequelae of cortisol exposure are known to profoundly impact the patient's quality of life. As...
10.
[Acromegaly and Cushing's disease: Persistence of comorbidities after the control of hypersecretion]
Rochette C, Castinetti F, Brue T
Ann Endocrinol (Paris)
. 2017 Jun;
77 Suppl 1:S19-S28.
PMID: 28645354
Acromegaly and Cushing's disease lead to common and distinct comorbidities. Currently available treatments lead to the control of hyper secretion in the majority of cases. However, the prevalence of the...